Park Seong-Cheol, Kwon Do Hoon, Lee Do Hee, Lee Jung Kyo
Department of Neurosurgery, Asan Medical Center, Seoul, Korea.
Department of Neurosurgery, Asan Medical Center, Seoul, Korea; Department of Neurosurgery, College of Medicine, University of Ulsan, Seoul, Korea.
World Neurosurg. 2016 Feb;86:371-83. doi: 10.1016/j.wneu.2015.08.056. Epub 2015 Sep 2.
To investigate adequate radiation doses for repeat Gamma Knife radiosurgery (GKS) for trigeminal neuralgia in our series and meta-analysis.
Fourteen patients treated by ipsilateral repeat GKS for trigeminal neuralgia were included. Median age of patients was 65 years (range, 28-78), the median target dose, 140-180). Patients were followed a median of 10.8 months (range, 1-151) after the second gamma-knife surgery. Brainstem dose analysis and vote-counting meta-analysis of 19 studies were performed.
After the second gamma-knife radiosurgeries, pain was relieved effectively in 12 patients (86%; Barrow Neurological Institute Pain Intensity Score I-III). Post-gamma-knife radiosurgery trigeminal nerve deficits were mild in 5 patients. No serious anesthesia dolorosa was occurred. The second GKS radiation dose ≤ 60 Gy was significantly associated with worse pain control outcome (P = 0.018 in our series, permutation analysis of variance, and P = 0.009 in the meta-analysis, 2-tailed Fisher's exact test). Cumulative dose ≤ 140-150 Gy was significantly associated with poor pain control outcome (P = 0.033 in our series and P = 0.013 in the meta-analysis, 2-tailed Fisher's exact test). A cumulative brainstem edge dose >12 Gy tended to be associated with trigeminal nerve deficit (P = 0.077).
Our study suggests that the second GKS dose is a potentially important factor.
在我们的系列研究和荟萃分析中,探讨三叉神经痛患者进行伽玛刀再次放射外科手术(GKS)的合适辐射剂量。
纳入14例接受同侧三叉神经痛再次GKS治疗的患者。患者的中位年龄为65岁(范围28 - 78岁),中位靶剂量为140 - 180 。第二次伽玛刀手术后,患者的中位随访时间为10.8个月(范围1 - 151个月)。对19项研究进行了脑干剂量分析和投票计数荟萃分析。
第二次伽玛刀放射外科手术后,12例患者(86%;巴罗神经学研究所疼痛强度评分I - III级)的疼痛得到有效缓解。5例患者伽玛刀放射外科手术后三叉神经功能缺损较轻。未发生严重的痛性麻木。第二次GKS辐射剂量≤60 Gy与较差的疼痛控制结果显著相关(在我们的系列研究中P = 0.018,方差置换分析,在荟萃分析中P = 0.009,双侧Fisher精确检验)。累积剂量≤140 - 150 Gy与较差的疼痛控制结果显著相关(在我们的系列研究中P = 0.033,在荟萃分析中P = 0.013,双侧Fisher精确检验)。累积脑干边缘剂量>12 Gy倾向于与三叉神经功能缺损相关(P = 0.077)。
我们的研究表明,第二次GKS剂量是一个潜在的重要因素。